Form 4 Tracker
CORCEPT THERAPEUTICS INC
CORT

84 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 16, 2025Jun 16 8:58 PMRobb Gary Charles
Proposed Sale
3,185$70.77$225.4K—

View →

Jun 10, 2025Jun 10 3:03 PMSwisher Daniel N JR
Proposed Sale
2,200$70.61$155.3K—

View →

Jun 3, 2025Jun 3 7:59 PMGuyer William
Proposed Sale
20,000$71.68$1.4M—

View →

Jun 2, 2025Jun 2 6:31 PMBELANOFF JOSEPH K
Proposed Sale
40,000$77.56$3.1M—

View →

Jun 2, 2025Jun 2 6:25 PMMaduck Sean
Proposed Sale
20,000$77.56$1.6M—

View →

Jun 2, 2025Jun 2 5:59 PMLyon Joseph Douglas
Proposed Sale
5,000$77.56$387.8K—

View →

May 20, 2025May 20 6:29 PMRobb Gary Charles
Proposed Sale
2,279$75.85$172.9K—

View →

May 16, 2025May 16 6:32 PMMAHONEY DAVID L
Proposed Sale
27,352$74.23$2.0M—

View →

May 16, 2025May 16 5:40 PMGuyer William
Proposed Sale
20,000$74.17$1.5M—

View →

May 12, 2025May 12 7:54 PMSwisher Daniel N JR
Proposed Sale
400$71.55$28.6K—

View →

May 12, 2025May 12 2:40 PMSwisher Daniel N JR
Proposed Sale
1,800$72.17$129.9K—

View →

May 2, 2025May 2 8:01 PMBELANOFF JOSEPH K
Proposed Sale
350$71.48$25.0K—

View →

May 2, 2025May 2 7:52 PMMaduck Sean
Proposed Sale
20,000$71.48$1.4M—

View →

May 1, 2025May 1 8:30 PMLyon Joseph Douglas
Proposed Sale
5,000$71.88$359.4K—

View →

Apr 10, 2025Apr 10 2:07 PMSwisher Daniel N JR
Proposed Sale
2,200$70.22$154.5K—

View →

Apr 1, 2025Apr 1 8:09 PMBELANOFF JOSEPH K
Proposed Sale
40,000$114.22$4.6M—

View →

Apr 1, 2025Apr 1 7:23 PMGuyer William
Proposed Sale
20,000$114.22$2.3M—

View →

Apr 1, 2025Apr 1 7:13 PMLyon Joseph Douglas
Proposed Sale
5,000$114.22$571.1K—

View →

Apr 1, 2025Apr 1 7:00 PMMaduck Sean
Proposed Sale
20,000$114.22$2.3M—

View →

Mar 31, 2025Mar 31 8:29 PMMaduck Sean
Proposed Sale
100,000$100.54$10.1M—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 2, 2026Oct 5 11:58 PMRoberto Wandenkolk VieiraPresident, Oncology
Option Exercise
8,333$21.63133,334(D)

View →

Oct 2, 2026Oct 5 11:54 PMJoseph Douglas LyonChief Accounting & Technology Officer
Option Exercise
9,190$19.2644,167(D)

View →

Oct 1, 2026Oct 5 11:54 PMJoseph Douglas LyonChief Accounting & Technology Officer
Option Exercise
810$13.563,357(D)

View →

Oct 2, 2026Oct 5 11:49 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
24,587$8.2741,986(D)

View →

Oct 1, 2026Oct 5 11:49 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
413$8.2766,573(D)

View →

Oct 1, 2026Oct 5 11:44 PMJustin Frederick GunnPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Grant/Award
100,000$114.03100,000(D)

View →

Sep 17, 2026Sep 18 11:47 PMGary Charles RobbChief Business Officer
Option Exercise
17,493$8.27182,507(D)

View →

Sep 14, 2026Sep 16 8:30 PMJoseph Douglas LyonChief Accounting & Technology Officer
Option Exercise
10,000$13.564,167(D)

View →

Sep 1, 2026Sep 4 1:16 AMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
25,000$8.2766,986(D)

View →

Sep 2, 2026Sep 4 1:02 AMRoberto Wandenkolk VieiraPresident, Oncology
Option Exercise
58,333$21.63141,667(D)

View →

Aug 26, 2026Aug 28 8:30 PMKimberly ParkDirector
Option Exercise
30,000$13.4930,000(D)

View →

Aug 25, 2026Aug 27 8:30 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
30,955$11.35169,045(D)

View →

Aug 14, 2026Aug 18 8:30 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
3,664$8.2791,986(D)

View →

Aug 10, 2026Aug 12 8:27 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
1,031$8.2795,650(D)

View →

Aug 10, 2026Aug 12 8:26 PMWilliam GuyerChief Development Officer
Option Exercise
16,300$21.65110,000(D)

View →

Aug 4, 2026Aug 6 10:44 PMWilliam GuyerChief Development Officer
Option Exercise
3,700$21.65126,300(D)

View →

Aug 3, 2026Aug 5 9:51 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
20,305$8.2796,681(D)

View →

Jul 30, 2026Aug 3 8:30 PMAtabak MokariChief Financial Officer
Option Exercise
80,000$23.0695,833(D)

View →

Jul 15, 2026Jul 17 10:31 PMAtabak MokariChief Financial Officer
Option Exercise
40,000$23.06175,833(D)

View →

Jul 7, 2026Jul 8 11:54 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65130,000(D)

View →

Page 1 of 3

Next →